Raymond James & Associates’s ThermoGenesis Holdings, Inc. Common Stock THMO Stock Holding History

Raymond James & Associates’s Portfolio THMO Stock Details THMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-65,004	Closed	-$46.4K	–	4113
2024 Q1	$46.4K	Hold	65,004	–	–	﹤0.01%	3809
2023 Q4	$39.1K	Hold	65,004	–	–	﹤0.01%	3728
2023 Q3	$89.7K	Buy	65,004 +15,000	+30%	+$19.2K	﹤0.01%	3614
2023 Q2	$64K	Buy	50,004 +25,000	+100%	+$43.6K	﹤0.01%	3686
2023 Q1	$65.5K	Buy	+25,004	New	+$87K	﹤0.01%	3708

Other funds holding THMO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Raymond James & Associates's THMO Position: Q2 2024 in Review

Raymond James & Associates sold out of ThermoGenesis Holdings, Inc. Common Stock (THMO) in Q2 2024, closing a stake of 65,004 shares — an estimated $46.4K sold.

Raymond James & Associates first reported a position in THMO in Q1 2023 and held it in 5 quarters. The position peaked at $89.7K in Q3 2023. 2 funds tracked by Wall St. Rank hold THMO as of Q2 2024.

Raymond James & Associates reported no remaining ThermoGenesis Holdings, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Raymond James & Associates sold 65,004 ThermoGenesis Holdings, Inc. Common Stock shares in Q2 2024, an estimated $46.4K.
Raymond James & Associates first reported a position in ThermoGenesis Holdings, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Raymond James & Associates's ThermoGenesis Holdings, Inc. Common Stock position peaked at $89.7K in Q3 2023.
2 funds tracked by Wall St. Rank held ThermoGenesis Holdings, Inc. Common Stock as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.